We are live on ! Find out more
ATHE

Alterity Therapeutics
ATHE

13 hedge funds and large institutions have $1.29M invested in Alterity Therapeutics in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

8% more funds holding

Funds holding: 12 → 13 (+1)

0% less ownership

Funds ownership: 0.01% → 0% (-0%)

11% less capital invested

Capital invested by funds: $1.45M → $1.29M (-$160K)

Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$50.1K
2
HF
HRT Financial
New York
+$37.9K
3
Renaissance Technologies
Renaissance Technologies
New York
+$17.9K
4
UBS Group
UBS Group
Switzerland
+$6.22K
5
Morgan Stanley
Morgan Stanley
New York
+$474

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$101K
2
Citadel Advisors
Citadel Advisors
Florida
-$36.6K

ATHE Hedge Fund Activity: Q2 2021 in Review

13 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q2 2021, worth a combined $1.29M — down 11% from $1.45M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ATHE positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $50.1K. The largest seller was Virtu Financial, exiting entirely with an estimated $101K sold.

  • 13 institutional investors held Alterity Therapeutics (ATHE) as of Q2 2021, up from 12 in Q1 2021.
  • Funds reported $1.29M of Alterity Therapeutics stock for Q2 2021, down 11% quarter-over-quarter.
  • 2 funds opened new Alterity Therapeutics positions in Q2 2021 and 1 closed out, a net change of +1 holder.
  • The largest Alterity Therapeutics buyer in Q2 2021 was Millennium Management, an estimated $50.1K added.
  • The largest Alterity Therapeutics seller in Q2 2021 was Virtu Financial, an estimated $101K sold.

Based on aggregated 13F filings for Q2 2021.